IL-17IL-17

Back to Disease

What Is the Efficacy of Ixekizumab Across the GRAPPA and EULAR Domains?

Efficacy & Safety of Ixekizumab ± Methotrexate in PsA (52-Week SPIRIT-H2H)

How Do You Explain The Timing of Ixekizumab's Clinical Efficacy to Patients?

What Is the Safety Profile of Ixekizumab in PsA and axSpa?

Describe The Mechanism of Action of Ixekizumab

Provide Immunologic Rationale For IL17-Directed Therapy in PsA, AS, and nr-axSpA

Describe the IL17-Induced Inflammatory Cascade

sectionimg

dotsimg

Download the app and start using it now.

Download on the App Store

GET IT ON Google Play